Physician profile
Kimberly D Fields
NPI 1467475947
$941.36
in general payments reported to CMS, 2019-2025
15 companies · $83.55 in 2025
The $83.55 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.64 · 2020: $14.15 · 2021: $175 · 2022: $309 · 2023: $181 · 2024: $94.52 · 2025: $83.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $365.61 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $94.70 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $92.44 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Mayne Pharma Commercial LLC | $83.01 | 2022-2023 | |
| Myovant Sciences INC. | $63.76 | 2021-2022 | |
| Abbvie INC. | $44.96 | 2021-2024 | |
| Organon LLC | $41.54 | 2022-2024 | |
| Pfizer INC. | $35.88 | 2022-2023 | |
| Duchesnay USA Incorporated | $30.10 | 2019 | |
| Shield Therapeutics INC | $22.97 | 2025 | |
| Lupin INC. | $14.91 | 2019 | |
| Ethicon US, LLC | $13.74 | 2021 | |
| Therapeuticsmd, INC. | $13.57 | 2022 | |
| Novo Nordisk INC | $12.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.